Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody–drug Conjugate Targeting AXL-expressing Cancers

por Zammarchi, Francesca, Havenith, Karin EG., Chivers, Simon, Hogg, Paul, Bertelli, Francois, Tyrer, Peter, Janghra, Narinder, Reinert, Halla W., Hartley, John A., van Berkel, Patrick H.
Publicado 2022